Merck's Drug Approved for Diarrhea Treatment in Children

Date : 01/27/2020 @ 12:32PM
Source : Dow Jones News
Stock : Merck and Co Inc (MRK)
Quote : 81.33  -1.01 (-1.23%) @ 9:36PM
After Hours
Last Trade
Last $ 81.13 ▼ -0.20 (-0.25%)

Merck's Drug Approved for Diarrhea Treatment in Children

Merck (NYSE:MRK)
Historical Stock Chart

1 Month : From Jan 2020 to Feb 2020

Click Here for more Merck Charts.

By Dave Sebastian

 

Merck & Co. (MRK) on Monday said the U.S. Food and Drug Administration has approved its new drug application for Dificid tablets to treat Clostridioides difficile-associated diarrhea in children aged six months and older.

The approval was based on the company's phase 3 study that involved 148 patients, Merck said.

Shares of Merck fell 0.73% in premarket trading.

 

Write to Dave Sebastian at dave.sebastian@wsj.com

 

(END) Dow Jones Newswires

January 27, 2020 07:17 ET (12:17 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Latest MRK Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.